Competitor Landscape: Spondyloarthritis

2018-11-30
Price :
Published : Nov-2018
No. of Pages : 64

Competitor Landscape: Spondyloarthritis

Summary

Sociable Pharma’s ‘Treatment Landscape’ contains evaluations of ongoing development activities within the spondyloarthritis (SpA) market, analysis of current & potential future product positioning, and forecast approval dates (by quarter) for candidates in Phase II development, or higher –
– Executive Summary: Contains analysis of key market events that have occurred during the previous month and which have impacted Sociable Pharma’s view of the disease landscape
– Landscape Updates: ‘Order of Entry’ analysis, detailing timeline forecasts for each drug in Phase II development or higher; Timeline forecasts for each approved product’s lifecycle management initiatives; ‘Market Entry’ & ‘Direction of Travel’ positioning analysis for pipeline & currently approved therapies
– Pipeline Landscape: An overview of pipeline candidates, containing snapshots of current development status; Expected drug-specific events & milestones until YE 2019
– Approved Product Landscape: An overview of pipeline candidates, containing snapshots of current development status; Expected drug-specific events & milestones until YE 2019

Key Highlights

– Given that only 187 patients are currently enrolled in upadacitinib’s Phase II/III SELECT-Axis 1 trial in AS, it is assumed that AbbVie will need to run a Phase III program before filing
– Secukinumab’s EU label update for PsA will bring it in-line with its US label, and is expected to become a key point of differentiation
– Change in primary completion date of the Phase III COAST-X trial is not expected to influence ixekizumab’s regulatory timeline in any way, with Lilly stating that it expects to file for regulatory approval of ixekizumab in AS and nr-axSpA, simultaneously, by YE 2018.

Scope

– The briefing is based on Sociable Pharma’s analysis of clinical trial data from company announcements (press releases, earnings calls) and clinical trial databases (clinicaltrials.gov)
– Sociable Pharma applies disease & drug specific assumptions in order to forecast US & EU approvals for drugs in Phase II development, or higher – these are outlined in the report Appendix
– Forecasts are presented in pipeline forecast figures & detailed tables
– ‘Market Entry’ & ‘Direction of Travel’ positioning analysis for pipeline & currently approved therapies is also provided.

Reasons to buy

– Provides details on forecast US & EU approvals for pipeline drugs in Phase II development or higher
– Includes potential positioning strategies that companies may adopt for their novel assets once they are approved & launched in the market
– Reviews ongoing lifecycle management strategies for existing players in the market
– A detailed methodology allows you to understand the forecast assumptions made, enabling cross comparison with your own internal forecasts.

Filed in: Pharmaceutical, Therapeutics
Publisher : GlobalData
More Reports
Title Price Buy Now

Central Nervous Systems Therapeutic Drug Monitoring – Medical Devices Pipeline Assessment, 2019

Central Nervous Systems Therapeutic Drug Monitoring - Medical Devices Pipeline Assessment, 2019 Summary GlobalData's Medical Devices sector report, "Central Nervous Systems Therapeutic Drug Monitoring - Medical Devices Pipeline Assessment, 2019" provides an overview of Central Nervous Systems Therapeutic Drug Monitoring currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Central Nervous Systems Therapeutic Drug Monitori......
$2500

Hemostasis Rapid Tests & Point of Care (POC) – Medical Devices Pipeline Assessment, 2019

Hemostasis Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2019 Summary GlobalData's Medical Devices sector report, "Hemostasis Rapid Tests & Point of Care (POC) - Medical Devices Pipeline Assessment, 2019" provides an overview of Hemostasis Rapid Tests & Point of Care (POC) currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hemostasis Rapid Tests & Point of Care (POC) pipeline products. This ......
$2500

Hematology Tests – Medical Devices Pipeline Assessment, 2019

Hematology Tests - Medical Devices Pipeline Assessment, 2019 Summary GlobalData's Medical Devices sector report, "Hematology Tests - Medical Devices Pipeline Assessment, 2019" provides an overview of Hematology Tests currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hematology Tests pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's te......
$4000

Urine Analysis – Medical Devices Pipeline Assessment, 2019

Urine Analysis - Medical Devices Pipeline Assessment, 2019 Summary GlobalData's Medical Devices sector report, "Urine Analysis - Medical Devices Pipeline Assessment, 2019" provides an overview of Urine Analysis currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Urine Analysis pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of in......
$2500

Organ Function Assays – Medical Devices Pipeline Assessment, 2019

Organ Function Assays - Medical Devices Pipeline Assessment, 2019 Summary GlobalData's Medical Devices sector report, "Organ Function Assays - Medical Devices Pipeline Assessment, 2019" provides an overview of Organ Function Assays currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Organ Function Assays pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary researc......
$2500

Female Fertility Rapid Tests – Medical Devices Pipeline Assessment, 2019

Female Fertility Rapid Tests - Medical Devices Pipeline Assessment, 2019 Summary GlobalData's Medical Devices sector report, "Female Fertility Rapid Tests - Medical Devices Pipeline Assessment, 2019" provides an overview of Female Fertility Rapid Tests currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Female Fertility Rapid Tests pipeline products. This report is prepared using data sourced from in-house databases, s......
$2500

Anemia Tests – Medical Devices Pipeline Assessment, 2019

Anemia Tests - Medical Devices Pipeline Assessment, 2019 Summary GlobalData's Medical Devices sector report, "Anemia Tests - Medical Devices Pipeline Assessment, 2019" provides an overview of Anemia Tests currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Anemia Tests pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry ex......
$2500

Immunoglobulin E (IgE) Allergy Blood Tests – Medical Devices Pipeline Assessment, 2019

Immunoglobulin E (IgE) Allergy Blood Tests - Medical Devices Pipeline Assessment, 2019 Summary GlobalData's Medical Devices sector report, "Immunoglobulin E (IgE) Allergy Blood Tests - Medical Devices Pipeline Assessment, 2019" provides an overview of Immunoglobulin E (IgE) Allergy Blood Tests currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Immunoglobulin E (IgE) Allergy Blood Tests pipeline products. This report i......
$2500

Bone Metabolism Assays – Medical Devices Pipeline Assessment, 2019

Bone Metabolism Assays - Medical Devices Pipeline Assessment, 2019 Summary GlobalData's Medical Devices sector report, "Bone Metabolism Assays - Medical Devices Pipeline Assessment, 2019" provides an overview of Bone Metabolism Assays currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Bone Metabolism Assays pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary res......
$2500

Self Testing – Medical Devices Pipeline Assessment, 2019

Self Testing - Medical Devices Pipeline Assessment, 2019 Summary GlobalData's Medical Devices sector report, "Self Testing - Medical Devices Pipeline Assessment, 2019" provides an overview of Self Testing currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Self Testing pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry ......
$2500
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy